Mucosal permeability after subclinical intestinal ischemia-reperfusion injury: An exploration of possible mechanisms

https://doi.org/10.1016/0022-3468(95)90133-7Get rights and content

Abstract

Changes in mucosal permeability may be important in the etiology of necrotizing enterocolitis. The authors have previously shown that subclinical ischemia-reperfusion injury results in increased permeability in the rat intestine, and have partially characterized this phenomenon. In the present study the authors attempt to determine the mechanism by which these changes occur. Six-week-old rats underwent 10-minute superior mesenteric artery occlusion (SMAO) or sham, and mucosal permeability to 51CrEDTA was measured after 30 minutes. Rats were pretreated with saline, inhibitors of oxygen free radicals (superoxide dismutase + catalase, vitamin E, allopurinol, α-phenyl-N-tert butyl-nitrone), inhibitors of eicosanoids (indomethacin, quinacrine, diethylcarbamazine, 13-azaprostanoic acid), the putative cytoprotective agent prostaglandin E2, or the inhibitor of neutrophil free radical production fructose 1–6 diphosphate. None of the agents significantly attenuated the increase in mucosal permeability caused by SMAO, although indomethacin and prostaglandin E2 significantly exacerbated the permeability changes. To further explore the role of neutrophils, tissue myeloperoxidase was measured 30 minutes after SMAO. There was no significant difference in myeloperoxidase levels between sham and SMAO animals. These data suggest that the early increase in mucosal permeability after subclinical ischemia-reperfusion injury is not mediated by oxygen free radicals, eicosanoids, or neutrophils. The deleterious effect of indomethacin and prostaglandin E2 suggests a possible protective role for the cyclooxygenase system, but further studies are necessary to elucidate this possibility.

References (53)

  • DN Granger et al.

    Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine

    Gastroenterol

    (1986)
  • DN Granger et al.

    Superoxide radicals in feline intestinal ischemia

    Gastroenterology

    (1981)
  • K Vohra et al.

    Ischemic injury to newborn rabbit ileum: Protective role of human superoxide dismutase

    J Pediatr Surg

    (1989)
  • SM Megison et al.

    Prolonged survival and decreased mucosal injury after low-dose enteral allopurinol prophylaxis in mesenteric ischemia

    J Pediatr Surg

    (1990)
  • T Mozes et al.

    Role of PGF2-alpha in the superior mesenteric artery-induced shock

    J Surg Res

    (1989)
  • MF Brown et al.

    The role of leukocytes in mediating injury of intestinal ischemia/reperfusion

    J Pediatr Surg

    (1990)
  • JC Langer et al.

    Corticosteroids do not alter mucosal permeability after subclinical intestinal ischemia-reperfusion injury in the rat

    Pediatr Surg Int

    (1994)
  • VK Mittal et al.

    Role of oxygen free radical scavengers in preservation of intestinal villi in the presence of ischemia

  • AL Tappel et al.

    In vivo lipid peroxidation: Measurement via exhaled pentane and protection by vitamin E

  • JG Garcia et al.

    Improved survival in intestinal ischemia by allopurinol not related to xanthineoxidase inhibition

    J Surg Res

    (1990)
  • EG Janzen et al.

    The effect of phenyl tert-butyl nitrone (PBN) on CC14-induced rat liver injury detected by proton magnetic resonance imaging (MRI) in vivo and electron microscopy (EM)

    Free Radic Res Commun

    (1990)
  • JL Grosfeld et al.

    Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia

    J Pediatr Surg

    (1983)
  • T Otamiri et al.

    Phospholipase A2 inhibition prevents mucosal damage associated with small intestinal ischaemia in rats

    Gut

    (1988)
  • W Hsueh et al.

    Platelet-activating factor-induced ischemic bowel necrosis: An investigation of secondary mediators in its pathogenesis

    Am J Pathol

    (1986)
  • C Lancaster et al.

    Intestinal lesions produced by prednisolone: Prevention (cytoprotection) by 16,16-dimethyl prostaglandin E2

    Am J Physiol

    (1978)
  • GB Bulkley

    Free radicals and other reactive oxygen metabolites: Clinical relevance and the therapeutic efficacy of antioxidant therapy

    Surgery

    (1993)
  • Cited by (30)

    • Vitamin E modulates apoptosis and c-jun N-terminal kinase activation in ovarian torsion-detorsion injury

      2013, Experimental and Molecular Pathology
      Citation Excerpt :

      It stabilizes the unsaturated fatty acid of the cell membrane, preventing oxidative stress (Singh et al., 2005). Therefore, tissues treated with vitamin E are likely to have an increased ability to scavenge oxygen-free radicals and to protect the membrane against lipid peroxidation (Langer et al., 1995). In addition, especially at high doses, vitamin E has been shown to decrease the release of proinflammatory cytokines, IL-8 and plasminogen activator inhibitor-1 levels and to reduce adhesion of monocytes to the endothelium (Singh et al., 2005).

    • Hypothermia and anesthetic postconditioning influence the expression and activity of small intestinal proteins possibly involved in ischemia/reperfusion-mediated events following cardiopulmonary resuscitation

      2012, Resuscitation
      Citation Excerpt :

      Based on these findings, our observation of increased HIF-1α protein levels under therapeutic HT and HT + SEV postconditioning may be interpreted as a potentially protective mechanism to reduce intestinal I/R-injury. Small intestinal I/R is associated with a loss of intestinal barrier function, bacterial translocation into the circulation, systemic inflammation and may lead to sepsis and multiorgan failure.15–17,28 Langer et al. demonstrated that in the rat intestine even short subclinical I/R (10 min superior mesenteric artery occlusion) results in increased permeability of the mucous barrier.16

    • Endotoxin level in ischemia-reperfusion injury in rats: Effect of glutamine pretreatment on endotoxin levels and gut morphology

      2010, Nutrition
      Citation Excerpt :

      In a broad sense, intestinal I/R disrupts the intestinal mucosal barrier. Urinary determination of inert, normally impermeable molecules, such as 51Cr-ethylenediaminetetra-acetic acid [5], mannitol, and lactulose, have been used to monitor intestinal permeability indirectly [35]. An impairment of barrier function of mucosa during intestinal I/R also promotes translocation of bacteria [36] and endotoxin [6,37].

    • Detection of intestinal bacterial translocation in subclinical ischemia- reperfusion using the polymerase chain reaction technique

      2000, Journal of Pediatric Surgery
      Citation Excerpt :

      It has been postulated that subclinical I/R injury to the intestine may result in increased mucosal permeability to noxious intraluminal proteins and bacteria, leading to bacterial translocation. Langer et al7,15 suggested that the increased mucosal permeability after the subclinical I/R injury led to bacterial translocations. They have used a weaning rat model to show that I/R injury results in an early reversible increasing mucosal permability to 51Cr EDTA, but they did not study bacterial translocation.7

    • Microvascular effects of oral interleukin-6 on ischemia/reperfusion in the murine small intestine

      2000, American Journal of Pathology
      Citation Excerpt :

      Since we have shown that orally administered IL-6 can reduce or eliminate bacterial translocation in hemorrhagic shock models,5,8,9 a detailed investigation of cellular events in the intestine after hemorrhage was carried out using the electron-dense marker HRP. HRP has been widely used to document blood flow and permeability in a number of models.13,14 The data presented in this report show that orally administered IL-6 restores intestinal circulation and reduces leakage of marker from the lumen to the circulation after hemorrhage.

    View all citing articles on Scopus

    Supported by Medical Research Council of Canada Grant No. MA-10878.

    View full text